Quadrant Capital Group LLC Procept Bio Robotics Corp Transaction History
Quadrant Capital Group LLC
- $1.42 Billion
- Q3 2024
A detailed history of Quadrant Capital Group LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Quadrant Capital Group LLC holds 52 shares of PRCT stock, worth $3,793. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52
Previous 28
85.71%
Holding current value
$3,793
Previous $1,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
273Shares Held
39.4MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$353 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$254 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$112 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$90.7 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$86 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.25B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...